Table 1.
Name | String testa | Antimicrobial susceptibility result (MICs, mg/L)b | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vitek 2 system | Agar dilution | Broth dilution | |||||||||||||||
TZP | CTT | CAZ | FEP | AMK | GEN | TOM | CIP | LEV | NIT | IMP | MEM | FOS | CAZ/AVI | TGC | CST | ||
CRKP-Urine1 | + | ≥128 | ≥64 | ≥64 | ≥64 | ≥64 | ≥16 | ≥16 | ≥4 | ≥8 | ≥512 | 128 | >128 | >1024 | 4/4 | 4 | <0.03 |
CRKP-Blood1 | + | ≥128 | ≥64 | ≥64 | ≥64 | ≥64 | ≥16 | ≥16 | ≥4 | ≥8 | ≥512 | 128 | >128 | >1024 | 2/4 | 4 | <0.03 |
CRKP-Blood2 | + | ≥128 | ≥64 | ≥64 | ≥64 | ≥64 | ≥16 | ≥16 | ≥4 | ≥8 | ≥512 | 128 | >128 | >1024 | 2/4 | 4 | <0.03 |
CRKP-Blood3 | + | ≥128 | ≥64 | ≥64 | ≥64 | ≥64 | ≥16 | ≥16 | ≥4 | ≥8 | 256 | 128 | >128 | 1024 | 4/4 | 4 | <0.03 |
CRKP-Urine2 | – | ≥128 | ≥64 | ≥64 | ≥64 | ≤2 | ≤1 | ≤1 | ≥4 | ≥8 | ≥512 | 128 | >128 | 32 | 2/4 | 8 | > |
CRKP-Pus1 | + | ≥128 | ≥64 | ≥64 | ≥64 | ≥64 | ≥16 | ≥16 | ≥4 | ≥8 | ≥512 | 128 | >128 | >1024 | 1/4 | 4 | 128 |
CRKP-Feces1 | – | ≥128 | 32 | 16 | 32 | ≥64 | ≥16 | ≥16 | ≥4 | ≥8 | ≥512 | 64 | 128 | 512 | <0.06/4 | 16 | 2 |
CRKP-Pus2 | + | ≥128 | ≥64 | 32 | ≥64 | ≥64 | ≥16 | ≥16 | ≥4 | ≥8 | ≥512 | 128 | >128 | >1024 | 2/4 | 4 | 128 |
CRKP-Pus3 | + | ≥128 | ≥64 | ≥64 | ≥64 | ≥64 | ≥16 | ≥16 | ≥4 | ≥8 | 256 | 128 | >128 | 1024 | 4/4 | 2 | 64 |
CRKP-Feces2 | – | 64 | ≥64 | 16 | 32 | ≥64 | ≥16 | ≥16 | ≥4 | ≥8 | 256 | 64 | >128 | >1024 | 2/4 | 128 | 0.06 |
CRKP-Feces3 | – | ≥128 | ≥64 | ≥64 | ≥64 | ≥64 | ≥16 | ≥16 | ≥4 | ≥8 | ≥512 | >128 | >128 | >1024 | 4/4 | 4 | <0.03 |
+, positive; –, negative.
TZP, piperacillin/tazobactam; CTT, cefotetan; CAZ, ceftazidime; FEP, cefepime; AMK, amikacin; GEN, gentamicin; TOM, tobramycin; CIP, ciprofloxacin; LEV, levofloxacin; NIT, nitrofurantoin; IMP, imipenem; MEM, meropenem; FOS, fosfomycin; CAZ/AVI, ceftazidime/avibactam; TGC, tigecycline; CST, colistin. Numbers shown in bold were resistance judged by CLSI breakpoint.